Although it is still unknown, the molecular mechanism linking KDM5C to p53, our data highlight the expression of high levels of the p53 protein strongly associated with an adverse outcome in GBM in tumor samples presenting high levels of KDM5C. This evidence concerns the gene TP53 and neoplasm.